Work

Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL/SLL or Richter's Syndrome

Year: 2020

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2020-138811

Authors: Jennifer L. Crombie, Svitlana Tyekucheva, Zixu Wang, Alexandra Savell, Lisa Brennan, Jessica Lowney, Karen Francoeur, Josie Montegaard, Austin I. Kim, Jacob D. Soumerai, Jon E. Arnason, Allan Louie Cruz, Sigrid Berg, David C. Fisher, Jennifer R Brown, Matthew S. Davids

Institutions: Dana-Farber Cancer Institute, Harvard University, Verastem (United States), Massachusetts General Hospital, Beth Israel Deaconess Medical Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097286939

FWCI: 1.66

Cites:

Cited by: 14

Related to: 10